Orexigen Therapeutics Inc (OREX) financial statements (2022 and earlier)

Company profile

Business Address 3344 N. TORREY PINES CT.
LA JOLLA, CA 92037
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments103,993214,011205,537176,996137,403
Cash and cash equivalents92,494155,422104,24398,12178,332
Short-term investments11,49958,589101,29478,87559,071
Restricted cash and investments90,005    
Receivables1,1026,8282,571  
Inventory, net of allowances, customer advances and progress billings23,19310,8021,198
Inventory23,19310,8021,198  
Prepaid expense and other current assets1,491
Deferred tax assets  547  
Other undisclosed current assets6,1682,2541,4731,286 
Total current assets:224,461233,895211,326178,282138,894
Noncurrent Assets
Property, plant and equipment1,0441,28485763083
Intangible assets, net (including goodwill)76,061  
Intangible assets, net (excluding goodwill)76,061    
Restricted cash and investments188138177177177
Other noncurrent assets2,8351,2726211,032
Total noncurrent assets:80,1282,6941,6551,839260
TOTAL ASSETS:304,589236,589212,981180,121139,154
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities45,62216,80815,46116,31212,116
Accounts payable15,2106,4854,2434,7873,811
Accrued liabilities30,41210,3236,5526,7514,345
Employee-related liabilities  4,6664,7743,960
Business combination, contingent consideration, liability15,000  
Deferred revenue and credits4,7389,6138,2293,4293,429
Other undisclosed current liabilities 5,8206,0243,1129,569
Total current liabilities:65,36032,24129,71422,85325,114
Noncurrent Liabilities
Liabilities, other than long-term debt12,66382,84177,01535,37538,571
Deferred revenue and credits5,86382,69176,11435,14338,571
Deferred tax liabilities, net  547  
Other liabilities 150354232 
Business combination, contingent consideration, liability6,800  
Total noncurrent liabilities:12,66382,84177,01535,37538,571
Total liabilities:78,023115,082106,72958,22863,685
Stockholders' equity
Stockholders' equity attributable to parent57,04433,37822,34441,86275,469
Common stock1514612310584
Additional paid in capital698,229653,704574,247556,235512,174
Accumulated other comprehensive income (loss)4,011215(26)(3)15
Accumulated deficit(645,211)(620,687)(552,000)(514,475)(436,804)
Total stockholders' equity:57,04433,37822,34441,86275,469
Other undisclosed liabilities and equity169,52288,12983,90880,031 
TOTAL LIABILITIES AND EQUITY:304,589236,589212,981180,121139,154

Income statement (P&L) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues33,70924,45955,5213,4283,428
Revenue, net27,91410,5941,292  
Cost of revenue
(Cost of Goods and Services Sold)
(7,995)    
Gross profit:25,71424,45955,5213,4283,428
Operating expenses(82,684)(84,512)(86,051)(80,626)(93,667)
Operating loss:(56,970)(60,053)(30,530)(77,198)(90,239)
Nonoperating income (expense)32,579(7,258)(6,907)(408)292
Investment income, nonoperating  8865147
Other nonoperating income (expense)32,579(7,258)(6,995)(473)145
Interest and debt expense18,287(7,446)(7,083)(538)(2)
Loss from continuing operations before equity method investments, income taxes:(6,104)(74,757)(44,520)(78,144)(89,949)
Other undisclosed income (loss) from continuing operations before income taxes(18,287)7,446   
Loss from continuing operations before income taxes:(24,391)(67,311)(44,520)(78,144)(89,949)
Income tax expense(133)(1,376)   
Net loss:(24,524)(68,687)(44,520)(78,144)(89,949)
Other undisclosed net income (loss) attributable to parent  6,995473(145)
Net loss available to common stockholders, diluted:(24,524)(68,687)(37,525)(77,671)(90,094)

Comprehensive Income ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(24,524)(68,687)(44,520)(78,144)(89,949)
Comprehensive loss:(24,524)(68,687)(44,520)(78,144)(89,949)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent3,7952426,972455(128)
Comprehensive loss, net of tax, attributable to parent:(20,729)(68,445)(37,548)(77,689)(90,077)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: